Regenerable Radical-Trapping Tellurobistocopherol Antioxidants by Poon, Jia Fei et al.
                          Poon, J. F., Yan, J., Singh, V. P., Gates, P., & Engman, L. (2016).
Regenerable Radical-Trapping Tellurobistocopherol Antioxidants. Journal of
Organic Chemistry, 81(24), 12540. https://doi.org/10.1021/acs.joc.6b02450
Peer reviewed version
Link to published version (if available):
10.1021/acs.joc.6b02450
Link to publication record in Explore Bristol Research
PDF-document
This is the accepted author manuscript (AAM). The final published version (version of record) is available online
via American Chemical Society at http://doi.org/10.1021/acs.joc.6b02450. Please refer to any applicable terms
of use of the publisher.
University of Bristol - Explore Bristol Research
General rights
This document is made available in accordance with publisher policies. Please cite only the published
version using the reference above. Full terms of use are available:
http://www.bristol.ac.uk/pure/about/ebr-terms
1 
 
Regenerable Radical-Trapping Tellurobistocopherol Antioxidants 
Jia-fei Poon, † Jiajie Yan,† Vijay P. Singh,† Paul J. Gates‡ and Lars Engman*,† 
†Uppsala University, Department of Chemistry – BMC, Box 576, SE-751 23 Uppsala, 
Sweden 
‡University of Bristol, School of Chemistry, Bristol, BS8 1TS, United Kingdom 
 
Abstract: Tellurobistocopherols 9-11 were prepared by lithiation of the corresponding 
bromotocopherols, reaction with tellurium tetrachloride and reductive work-up. 
Compounds 9-11 quenched linoleic acid-derived peroxyl radicals much more 
efficiently than -tocopherol in a chlorobenzene/water two-phase system. 
N-Acetylcysteine or tris(2-carboxylethyl)phosphine as co-antioxidants in the aqueous 
phase could regenerate the tellurobistocopherols and increase their inhibition times. 
Antioxidant 11 inhibited peroxidation for seven-fold longer than recorded with 
-tocopherol. Thiol-consumption in the aqueous phase was monitored and found to be 
inversely related to the inhibition time.  
 
Oxidative stress is characterized by an imbalance between the production of reactive 
oxygen species (ROS) and the antioxidant defense systems in favour of the former.1 
ROS is known to target lipids in biological systems and this is generally known as lipid 
peroxidation, an undesired free radical process whereby organic substances, RH, are 
oxidized to the corresponding hydroperoxides, ROOH (eq 1). 
Vitamin E, the most important lipid-soluble antioxidant in man, offers protection 
against lipid peroxidation. Briefly, vitamin E (AH) competes with the propagation 
event and scavenges peroxyl radicals, ROO·, by hydrogen-atom transfer (HAT) with a 
rate kinh >> kprop (eq 2). The resulting resonance-stabilized radical A· is unable to 
propagate the reaction. 
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Vitamin E was first reported by Evans and Bishop in 19222 but its antioxidant 
properties were revealed by Emerson and co-workers when they showed that it could 
slow down the autoxidation of fats.3 Vitamin E is a collective name for a family of 
compounds including four tocopherols and four tocotrienols. Structurally, they are all 
6-chromanols. They differ in the number and position of methyl groups in the phenolic 
part and in the side-chain which is saturated in tocopherols 1-4 and triply unsaturated in 
the corresponding tocotrienols. In the tocopherol family, α-tocopherol (1) is the most 
reactive compound (kinh = 3.2 x 10
6 M-1s-1).4  
 
 
 
                 
Considerable efforts have been invested in order to improve the reactivity of 1. Ingold 
and coworkers found that compound 5 was a slightly more reactive antioxidant (kinh = 
4.7 x 106 M-1s-1) 5 due to better overlap between the chromane oxygen lone pair and the 
aromatic ring, resulting in a lower bond dissociation energy, BDEO-H, of the phenol. 
More recently, Pratt and coworkers introduced nitrogen into the aromatic ring of 
-tocopherol. Thus, strongly electron-donating groups such as amines could be 
installed to lower the BDEO-H while the ionization potential of the compound did not 
drop below the critical point where electron transfer to dioxygen becomes a problem. 
Naphthyridinols 6, representing compounds of this type, were recently found to 
1 α-Tocopherol R1= R2 = Me                
2 β-Tocopherol R1 = Me; R2 = H                
3 γ-Tocopherol R1 = H; R2 = Me                
4 δ-Tocopherol R1 = R2 = H 
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efficiently quench peroxyl radicals in lipid bilayers.6 Suitably positioned chalcogens 
(Se, S) have also been found to increase the radical trapping activity of phenolic 
compounds.7 
Recently, our group showed that alkyltelluro substituted ß-, γ- and δ-tocopherols 7a-7d 
were at least 10-fold more reactive as radical-trapping agents than their respective 
parents.8  
 
Computational studies on alkyltelluro phenols suggested that oxygen-atom transfer 
from the peroxyl radical to tellurium is a key step in the antioxidant mechanism. The 
resulting alkoxyl radical in the solvent cage can then abstract a hydrogen-atom from the 
phenolic O-H.9 Regeneration of the antioxidant from the phenoxyl radical/telluroxide 
formed was brought about by thiols (Figure 1). Indeed, the inhibition time for 
compound 7 was 6.5-fold longer than recorded with α-tocopherol in a two-phase lipid 
peroxidation system. 
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Figure 1. Proposed catalytic mechanism for quenching of peroxyl radicals by 
2-(alkyltelluro)phenols in the presence of thiols. 
 
It occurred to us that it may be possible to benefit even more from the unusual reactivity 
of the heteroatom. The idea that emerged was to link two molecules of a tocopherol to 
tellurium. Surprisingly, only very few compounds of this kind are reported in the 
literature. They include the methano- and ethano dimers 8.10 To the best of our 
knowledge, dimers linked together by a chalcogen are as yet unknown.  
Synthesis: Symmetrical diorganyl tellurides can be obtained in high yields by 
copper-induced detelluration of the corresponding diorganyl ditellurides.11 This 
procedure was tried for the preparation of tellurobistocopherol 9. Although the 
ditelluride required was conveniently obtained from 5-bromo--tocopherol by 
dilithiation, Te-insertion into the C-Li bond and air-oxidation, extrusion of tellurium 
was unsuccessful. Instead, we were pleased to find that a similar strategy, using TeCl4 
in place of elemental tellurium, provided compound 9 in low yield after reductive 
work-up (eq 3). 
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In a similar fashion, 7-bromo-β-tocopherol and 7-bromo-δ-tocopherol provided the 
corresponding tellurobistocopherols 10 and 11 in 33% and 26% yield, respectively. 
Curious to study the effects of the phytyl chain, the methyl groups and the 
benzannulated cyclic ether on antioxidant capacity, compounds 12 and 13 were 
prepared using a similar procedure. 
 
Evaluation: To determine the radical-trapping capacity and regenerability, all 
tellurobisphenolic antioxidants were evaluated in a two-phase lipid peroxidation 
system reminiscent of a biological membrane.12 Briefly, 
azobis(2,4-dimethylvaleronitrile) (AMVN) was added as an initiator to chlorobenzene 
at 42°C containing the antioxidant and linoleic acid as the oxidizable substrate. The 
aqueous phase contained N-acetylcysteine (NAC) or tris(2-carboxylethyl)phosphine 
(TCEP) which could serve as co-antioxidants and continuously regenerate the 
6 
 
antioxidants in the lipid phase. The chlorobenzene phase was assayed by HPLC every 
20 minutes and the concentration of conjugated diene, formed by peroxidation of 
linoleic acid, was determined by HPLC with UV-detection at 234 nm. Initially, lipid 
peroxidation is efficiently inhibited by the antioxidant and the rate of conjugated diene 
formation, Rinh, is low. After some time, when the antioxidant is all consumed, the 
R-value increases considerably to a value corresponding to uninhibited peroxidation. 
This point is referred to as the inhibition time, Tinh, of the antioxidant. Our reference 
compound, -tocopherol, at 40 M could inhibit peroxidation efficiently (Rinh = ca. 25 
μM/h) for ca. 100 min in the presence of aqueous phase NAC or TCEP (Figure 1 and 
Table 1). The similar Tinh- and Rinh-values recorded in the absence of the co-antioxidant 
show that -tocopherol is not regenerable under the conditions of the two-phase model. 
 
In the absence of NAC/TCEP, all organotellurium antioxidants tested quenched peroxyl 
radicals at least (Rinh = 7 – 25 μM/h), as efficiently as 1. For compounds 9-11 the 
Tinh-values (165-214 min) were significantly longer than recorded for -tocopherol. 
 
 
Figure 2. Peroxidation traces (conjugated diene concentration vs time) recorded using 
compound 11 and α-tocopherol as antioxidants in chlorobenzene and NAC (1 mM) in 
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the aqueous phase.  
 
When NAC (1 mM) was present in the aqueous phase, the Rinh-values were 
significantly lower for all compounds (Rinh = 1 – 4 μM/h) and the Tinh-values longer 
(Table 1). 7,7’-Tellurobis--tocopherol (11) inhibited peroxidation for 742 min or 
7.6-fold longer than recorded for 11 (Figure 2). This is the longest inhibition time we 
have ever recorded in the two-phase model. Removal of the phytyl chain and the 
 
Table 1. Inhibited Rates of Conjugated Diene Formation (Rinh) and Inhibition Times 
(Tinh) in the Presence and Absence of NAC (1.0 mM) or TCEP (0.5 mM) in the 
Two-phase Model 
Antioxidants 
(40 M) 
With NAC With TCEP Without NAC/TCEP 
Rinh
a 
(μM/h) 
Tinh
b 
(min) 
Rinh
a
 
(μM/h) 
Tinh
b 
(min) 
Rinh
a
 
(μM/h) 
Tinh
b
 
(min) 
9 1 ± 1 634 ± 9 2 ± 0 451 ± 9 8 170 
10 2 ± 0 653 ± 12 2 ± 1 510 ± 5 7 165 
11 4 ± 1 742 ± 13 2 ± 0 507 ± 8 21 214 
12 1 ± 1 544 ± 4 2 ± 1 208 ± 10 25 92 
13 2 ± 1 365 ± 6 3 ± 1 125 ± 13 11 49 
α-Tocopherol 25 ± 1 97 ± 15 21 ± 2 123 ± 7 28 109 
aRate of peroxidation during the inhibited phase (uninhibited rate ca. 479 µM/h). Errors 
correspond to ± SD for triplicates. bInhibited phase of peroxidation. Reactions were 
monitored for 880 min. Errors correspond to ± SD for triplicates. 
 
2,2´,8,8´ methyls caused a drop in the inhibition time (compound 12; Tinh = 544 min), 
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which continued upon further simplification of the structure (compound 13; Tinh = 365 
min). We speculate that this is a lipophilicity effect or the result of an increasing 
BDEO-H (vide infra). 
When TCEP (0.5 mM) was used as a co-antioxidant, similarly low Rinh-values were 
recorded as with NAC (Table 1). Whereas the inhibition times were generally shorter, 
the similar trend was seen when the compounds were arranged according to falling Tinh. 
We were also curious to see how quickly NAC was consumed during a normal 
peroxidation experiment. Following a recently described procedure,13 the aqueous 
phase was sampled every 30 minutes and the thiol was allowed to react with 
bis-4-pyridyl disulfide. The concentration of pyridine-4-thiol formed (eq 4), as 
determined by UV-spectroscopy at 324 nm, was used for monitoring the disappearance 
of NAC with time.  
 
For α-tocopherol, the rate of NAC-consumption (33 µM/h) was low and essentially the 
same as recorded in control experiments (nothing but NAC in the two-phase system or 
NAC + linoleic acid + AMVN; Table 2). When a telluride antioxidant was present, the 
NAC was consumed more quickly. In the presence of tellurobistocopherols 9-11, 119 – 
131 µM/h of the thiol was consumed. The rate increased to 150 and 164 µM/h, 
respectively, with compounds 12 and 13. 
 
 
 
 
9 
 
Table 2. NAC-Consumption in the Aqueous Phase during Peroxidation Inhibited by 
Telluriobisphenol Antioxidants 
Antioxidant  
(40 µM) 
Rate of NAC-Consumption 
(µM/h)a 
9 131 ± 4 
10 125 ± 10 
11 119 ± 13 
12 150 ± 10 
13 164 ± 4 
α-Tocopherol 33 ± 4 
_b 37 ± 8 
_c 27 ± 5 
aErrors correspond to ± SD for triplicates. bLinoleic acid and AMVN in the 
chlorobenzene and NAC in the aqueous phase. cNothing in the chlorobenzene and 
NAC in the aqueous phase. 
Thus, the rate of thiol consumption is inversely related to the Tinh recorded in the 
two-phase model. Extrapolation in the NAC-concentration vs time plots to find the time 
where the aqueous phase was depleted of NAC, showed that this always fell short of the 
corresponding Tinh. It therefore seems that the availability of aqueous-phase NAC is a 
limiting factor for the inhibition time. 
In an attempt to see if the turnover number of catalyst 11 could be increased, the 
concentration was lowered from the standard 40 M to 30, 20, 10 and 5 M. As shown 
in Figure 3, this was not the case. When the concentration was lowered, the Tinh was 
accordingly reduced. A similar trend was seen with TCEP. 
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Figure 3. Inhibition times recorded for 11 at different concentrations in the presence of 
NAC (1.0 mM) or TCEP (0.5 mM).  
 
Concluding Remarks 
As observed previously with the “monomeric” tocopherol derivatives 7, the “dimeric” 
tellurobistocopherols 9-11 showed considerable antioxidant capacity also in the 
absence of a co-antioxidant. This may be because the heteroatom is sterically protected. 
Otherwise, residual amounts of linoleic acid hydroperoxide tend to oxidize the telluride 
antioxidant to the corresponding telluroxide, which is considerably less reactive 
towards peroxyl radicals. 
In the presence of NAC as a co-antioxidant, Tinh-values for the “dimers” 9-11 were 
always longer but never close to twice as long as recorded for the 
corresponding ”monomers” 7a-7d. 8b The largest improvement, +38%, was seen with 
-tocopherol derivative 9 (634 min instead of 458 min for the corresponding monomer 
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tellurides are chemically more robust than alkyl aryl tellurides. Some time ago we 
probed the stabilizing capacity of a series of electron-rich diaryl tellurides is polymeric 
materials.14 As determined by thermogravimetric analysis many of the compounds 
were stable at least up to 210o C. Diaryl tellurides as well as alkyl aryl tellurides are 
easily oxidized to the corresponding telluroxides. In case the system is depleted in 
reducing agents, there is a risk that the alkyl aryl telluroxide (but not the diaryl 
telluroxide) may decompose via a telluroxide elimination reaction.15  
The reactivity of the tellurobistocopherols did not change much upon removal of the 
phytyl chain, the 2,2’,8,8’-methyls and the benzannulated cyclic ether. However, a 
noteworthy drop in the Tinh was recorded for compounds 12 and 13. This could be a 
lipophilicity effect. Highly lipophilic antioxidants would distribute almost exclusively 
into the lipid phase and give a maximal antioxidant protection there. Removal of the 
benzannulated cyclic ether and any methyl groups flanking the aromatic OH would also 
be expected to cause an increase in the BDEO-H (electron donating substituents here are 
known to weaken the O-H bond). This would increase leakage of chain-propagating 
alkoxyl radicals from the solvent cage into the bulk of the solution (Figure 1). 
Whenever this happens, 2 equivalents of thiol are wasted in order to regenerate the 
catalyst. In fact, such an increase in the rate of thiol consumption was observed for 
compounds 12 and 13. 
 
Experimental Section 
1H and 13C NMR spectra were recorded on 400 MHz (1H: 399.97 MHz; 13C 100.58 
MHz) and 500 MHz (1H: 499.93 MHz; 13C: 125.70 MHz) spectrometers, using the 
residual solvent peaks of CDCl3 (
1H: δ 7.26; 13C: δ 77.0) as an indirect reference to 
TMS. 125Te NMR spectra were recorded on a 400 MHz spectrometer (125Te: 126.19 
MHz) using Ph2Te2 (423 ppm) as external standard. The melting points are uncorrected. 
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Flash column chromatography was performed using silica gel (0.04 – 0.06 mm). 
Tetrahydrofuran was dried in a solvent purification system by passing it through an 
activated alumina column. 5-Bromo-δ-tocopherol,8b 7-bromo-δ-tocopherol8b and 
7-bromo-β-tocopherol8b and 6-bromochromane16 were prepared according to literature 
procedures.  
 
General procedure: Synthesis of tellurobisphenols 
To a solution of the appropriate 2-bromophenol derivate (1.0 eq.) in anhydrous THF (10 
mL) at -78 oC under nitrogen, tert-butyl lithium (1.7 M in pentane, 3.0 eq.) was added. 
After stirring for 2 hours at -78 oC, tellurium tetrachloride (0.5 eq.) was added and the 
solution was allowed to stir for overnight at ambient temperature. After addition of 
Na2SO3 (aq., 20 mL) and extraction with diethyl ether (25 mL x 3), the organic layer 
was dried over magnesium sulfate, filtered and evaporated under reduced pressure. The 
residue was purified by column chromatography (pentane/ethyl acetate = 90:10) to give 
the title compound. 
 
5,5´-Tellurobis--tocopherol (9). 5-Bromo-δ-tocopherol (964 mg, 2.0 mmol), 
tert-butyl lithium (1.7 M in pentane, 3.5 mL, 6.0 mmol) and tellurium tetrachloride 
(269 mg, 1.0 mmol) were reacted according to the general procedure to give the title 
compound as a yellow oil (225 mg, 24%). 1H NMR (400 MHz, CDCl3):  6.71 (s, 2H), 
6.33 (s, 2H), 2.82 (m, 4H), 2.14 (s, 6H), 1.78 (m, 4H), 1.08-1.58 (several peaks, 48H), 
0.87-0.91 (several peaks, 24H). 13C NMR (100 MHz, CDCl3):  150.9, 146.3, 130.4, 
125.5, 114.5, 102.0, 75.2, 39.7, 39.4, 37.5, 37.4, 37.3, 32.8, 32.7, 32.2, 28.7, 28.0, 24.8, 
24.4, 23.7, 22.7, 22.6, 21.0, 19.8, 19.6, 16.3. 125Te NMR (126 MHz, CDCl3): δ -3. 
HRMS (TOF MS EI+) m/z calcd for C54H90O4Te [M]
+: 932.5901. Found: 932.5928. 
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7,7´-Tellurobis--tocopherol (10). 7-Bromo-β-tocopherol (496 mg, 1.0 mmol), 
tert-butyl lithium (1.7 M in pentane, 1.8 mL, 3.0 mmol) and tellurium tetrachloride 
(134 mg, 0.5 mmol) were reacted according to the general procedure to give the title 
compound as a yellow oil (158 mg, 33%). 1H NMR (400 MHz, CDCl3):  5.73 (s, 2H), 
2.62 (t, J = 6.4 Hz, 4H), 2.42 (s, 6H), 2.12 (s, 6H), 1.77 (m, 4H), 1.01-1.56 (several 
peaks, 48H), 0.83-0.88 (several peaks, 24H).13C NMR (125 MHz, CDCl3):  148.6, 
145.5, 129.1, 123.1, 119.1, 105.3, 75.0, 39.8, 39.4, 37.4, 37.3, 32.8, 32.7, 31.4, 28.0, 
24.8, 24.4, 23.7, 22.7, 22.6, 21.2, 21.1, 20.9, 19.8, 19.6, 12.6. 125Te NMR (126 MHz, 
CDCl3): δ 33. HRMS (MALDI) m/z calcd for C56H94O4Te [M]+: 960.6214. Found: 
960.6217. 
 
7,7´-Tellurobis--tocopherol (11). 7-Bromo-δ-tocopherol (964 mg, 2.0 mmol), 
tert-butyl lithium (1.7 M in pentane, 3.5 mL, 6.0 mmol) and tellurium tetrachloride 
(269 mg, 1.0 mmol) were reacted according to the general procedure to give the title 
compound as a yellow oil (238 mg, 26%). 1H NMR (400 MHz, CDCl3):  6.65 (s, 2H), 
6.61 (s, 2H), 2.68 (m, 4H), 2.52 (s, 6H), 1.75 (m, 4H), 1.06-1.60 (several peaks, 48H), 
0.88-0.92 (several peaks, 24H). 13C NMR (100 MHz, CDCl3):  150.5, 145.4, 132.5, 
124.0, 111.5, 105.9, 76.0, 40.1, 39.4, 37.4, 37.3, 32.8, 32.7, 31.2, 28.0, 24.8, 24.4, 24.0, 
22.7, 22.6, 22.5, 22.4, 21.0, 19.7, 19.6. 125Te NMR (126 MHz, CDCl3): δ 49. HRMS 
(TOF MS ESI) m/z calcd for C54H90O4Te [M+Na]
+: 955.5794. Found: 955.5801. 
 
6-Chromanol. To a mixture of magnesium turnings (248 mg, 10.2 mmol) and iodine 
(90 mg, 0.35 mmol) in THF (4 mL) under nitrogen was added a solution of 
6-bromochromane (378 mg, 1.8 mmol) in anhydrous THF (2 mL). After heating at 60 
°C for 20 min, a solution of 6-bromochromane (1.14 g, 5.3 mmol) in anhydrous THF (6 
mL) was added dropwise over a period of 50 min at 30 °C. The Grignard reagent was 
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transferred to a solution of trimethyl borate (0.79 mL, 7.1 mmol) in anhydrous THF (4 
mL) at -10 °C over a period of 1 hour. The reaction mixture was allowed to stir for 30 
min prior to hydrolysis with HCl (2 M, 12 mL) and extraction with diethyl ether (10 
mL). The organic phase was washed with water (10 mL x 2) and then transferred to a 
two-neck round-bottomed flask. To the solution, peracetic acid (1.2 mL, 39% in acetic 
acid) was added dropwise at 0°C under nitrogen. After stirring at ambient temperature 
for 3 hours, the reaction mixture was quenched with NaHSO3 (10% aq., 30 mL) and 
extracted with diethyl ether (30 mL x 3). The organic layer was dried over magnesium 
sulfate, filtered and evaporated under reduced pressure. The residue was purified by 
column chromatography (pentane/ethyl acetate = 95:5) to give the title compound as a 
white solid. 1H NMR (400 MHz, CDCl3): 6.67 (d, J = 8.8 Hz, 1H), 6.57 (dd, J = 2.8, 8.8 
Hz, 1H), 6.53 (d, J = 2.8 Hz, 1H), 4.40 (s, 1H), 4.13 (t, J = 4.8 Hz, 2H), 2.74 (d, J = 6.4 
Hz, 2H), 1.98 (m, 2H). 13C NMR (100 MHz, CDCl3): 148.9, 148.8, 123.0, 117.3, 115.8, 
114.3, 66.3, 25.0, 22.4. 1H and 13C spectra were in accord with the literature.17 
 
5-Bromo-6-chromanol. To a solution of 6-chromanol (651 mg, 4.3 mmol) in 
dichloromethane (50 mL), a solution of tetrabutylammonium tribromide (2.1 g, 4.3 
mmol) in dichloromethane (50 mL) was added dropwise. After stirring for one hour, the 
solution was evaporated and the residue was purified by column chromatography 
(pentane/ethyl acetate = 95:5) to give the title compound as a white solid (685 mg, 
70%). 1H NMR (400 MHz, CDCl3):  6.82 (d, J = 6.8 Hz, 1H), 6.73 (d, J = 6.8 Hz, 1H), 
5.16 (s, 1H), 4.08 (m, 2H), 2.73 (t, J = 5.6 Hz, 2H), 2.02 (m, 2H). 13C NMR (100 MHz, 
CDCl3):  149.5, 146.1, 1221, 116.8, 113.9, 112.6, 65.8, 26.3, 22.3. 1H and 13C spectra 
were in accord with the literature.17 
 
5,5'-Tellurobis-6-chromanol (12). 5-Bromo-6-chromanol (458 mg, 2.0 mmol), 
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tert-butyl lithium (1.7 M in pentane, 3.5 mL, 6.0 mmol) and tellurium tetrachloride 
(269 mg, 1.0 mmol) were reacted according to the general procedure to give the title 
compound as a red solid (135 mg, 32%). Mp = 158-160 °C. 1H NMR (500 MHz, 
CDCl3):  6.79 (d, J = 9.0 Hz, 2H), 6.73 (d, J = 9.0 Hz, 2H), 6.23 (s, 2H), 4.03 (t, J = 5.0 
Hz, 4H), 2.80 (t, J = 7.0 Hz, 4 H), 1.98 (m, 4H). 13C NMR (125 MHz, CDCl3):  151.9, 
149.1, 127.5, 120.0, 113.0, 106.4, 65.7, 31.2, 23.2. 125Te NMR (126 MHz, CDCl3) δ 
216. HRMS (TOF MS EI+) m/z calcd for C18H18O4Te [M]
+: 428.0267. Found: 
428.0272. 
 
2,2´-Tellurobisphenol (13). 2-Bromophenol (692 mg, 4.0 mmol), tert-butyl lithium 
(1.7 M in pentane, 7.0 mL, 12.0 mmol) and tellurium tetrachloride (538 mg, 2.0 mmol) 
were reacted according to the general procedure to give the title compound as a pale 
yellow solid (270 mg, 44%). 1H NMR (500 MHz, CDCl3):  7.52 (dd, J = 2.0, 8.0 Hz, 
2H), 7.26 (m, 2H), 6.96 (dd, J = 1.5, 8.5 Hz, 2H), 6.78 (m, 2H), 5.92 (s, 1H). 13C NMR 
(100 MHz, CDCl3):  156.9, 139.5, 131.3, 122.2, 114.2, 102.2. 125Te NMR (126 MHz, 
CDCl3) δ 285. The 1H spectrum was in accord with the literature.18 
 
HPLC Peroxidation Assay. The experimental setup for the two-phase lipid 
peroxidation model for determination of Rinh and Tinh has been recently described.
12 The 
values for Rinh and Tinh in the presence of NAC and TCEP are reported as means ± SD 
based on triplicates. The initial concentration of linoleic acid hydroperoxide was ca. 
175 μM at the beginning of each experiment. 
 
NAC-consumption Assay. The experimental setup for determination of the rate of 
NAC-consumption in the two-phase lipid peroxidation model was recently described.13 
The values reported are means ± SD based on triplicates. 
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